Background The current review broadly summarises the evidence base for
pharmacotherapies and adjunctive and alternative therapies in the treatment of eating …

Explanatory models for eating disorders have changed over time to account for changing
clinical presentations. The transdiagnostic model evolved from the maintenance model …

Background: Eating disorders are serious mental disorders and are associated with
substantial economic and social burden. The aim of this study is to undertake a systematic …

Objective To determine the cost‐effectiveness of individual face‐to‐face cognitive
behavioral therapy (CBT) compared to therapist guided Internet‐based self‐help (GSH‐I) in …

Objective This systematic review updates an existing review examining the cost‐
effectiveness of interventions to prevent and treat eating disorders (EDs). Method Literature …

Oral lisdexamfetamine dimesylate (Vyvanse®; lisdexamfetamine), a prodrug of
dextroamfetamine, is currently the only drug to be approved in the USA for the treatment of …

Introduction: The indications for lisdexamfetamine (LDX), a central nervous system stimulant,
were recently expanded to include treatment of moderate to severe binge eating disorder …

Background Preliminary placebo-controlled evidence paved the ground to the US Food and
Drug Administration approval extension of lisdexamfetamine for the treatment of moderate-to …

Introduction Binge-eating disorder (BED) is a complex and disabling eating disorder (ED)
associated with considerable burden and impairments in quality of life and physical/mental …

Eating disorder animal model : Current Opinion in Psychiatry Eating disorder animal model :
Current Opinion in Psychiatry Log in or Register Subscribe to journalSubscribe Get new issue …